Publications

TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination
Link  |  PDF

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study
Link  |  PDF

Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology
Link  |  PDF

Genomic Predictors for Radiation Sensitivity and Toxicity in Breast Cancer—from Promise to Reality
Link   |  PDF

Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial
Link  |  PDF

Comparison of partial-breast irradiation and intraoperative radiation to whole-breast irradiation in early-stage breast cancer patients: a Kaplan-Meier-derived patient data meta-analysis
Link  |  PDF

The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions
Link  |  PDF

Racial/Ethnic Disparities in Genomic Sequencing
Link  |  PDF

Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer A Review
Link  |  PDF

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer:
a matched, retrospective analysis
Link  |  PDF

PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
Link  |  PDF

Modulating the Radiation Response for Improved Outcomes in Breast Cancer
Link  |  PDF

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
Link  |  PDF

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
Link  |  PDF

RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes
Link  |  PDF

Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial
Link  |  PDF

Genomic Predictors for Radiation Sensitivity and Toxicity in Breast Cancer—from Promise to Reality
Link  |  PDF

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
Link  |  PDF

Check for Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN updates Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
Link  |  PDF

Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers
Link  |  PDF

Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy
Link  |  PDF

Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial
Link  |  PDF

TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-b signaling
Link  |  PDF

Impact of sequencing of androgen receptor‐signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption
Link  |  PDF

ARe we there yet? Understanding androgen receptor signaling in breast cancer
Link  |  PDF

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
Link  |  PDF

Degrading AR-dependent cancers: Expanding the role of PROTACs
Link  | PDF

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
Link  |  PDF